Toggle Main Menu Toggle Search

Open Access padlockePrints

Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort

Lookup NU author(s): Professor Caroline Relton

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Experimental and epidemiological data suggest that vitamin D play a role in pathogenesis and progression of cancer, but prospective data on head and neck cancer (HNC) and oesophagus cancer are limited. The European Prospective Investigation into Cancer and Nutrition (EPIC) study recruited 385,747 participants with blood samples between 1992 and 2000. This analysis includes 497 case-control pairs of the head and neck and oesophagus, as well as 443 additional controls. Circulating 25(OH)D-3 were measured in pre-diagnostic samples and evaluated in relation to HNC and oesophagus cancer risk and post-diagnosis all-cause mortality. After controlling for risk factors, a doubling of 25(OH)D-3 was associated with 30% lower odds of HNC (OR 0.70, 95% confidence interval [95% CI] 0.56-0.88, P-trend = 0.001). Subsequent analyses by anatomical sub-site indicated clear inverse associations with risk of larynx and hypopharynx cancer combined (OR 0.55, 95CI% 0.39-0.78) and oral cavity cancer (OR 0.60, 95CI% 0.42-0.87). Low 25(OH)D-3 concentrations were also associated with higher risk of death from any cause among HNC cases. No clear association was seen with risk or survival for oesophageal cancer. Study participants with elevated circulating concentrations of 25(OH)D-3 had decreased risk of HNC, as well as improved survival following diagnosis.


Publication metadata

Author(s): Fanidi A, Muller DC, Midttun O, Ueland PM, Vollset SE, Relton C, Vineis P, Weiderpass E, Skeie G, Brustad M, Palli D, Tumino R, Grioni S, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Boutron-Ruault MC, Kvaskoff M, Cadeau C, Huerta JM, Sanchez MJ, Agudo A, Lasheras C, Quiros JR, Chamosa S, Riboli E, Travis RC, Ward H, Murphy N, Khaw KT, Trichopoulou A, Lagiou P, Papatesta EM, Boeing H, Kuehn T, Katzke V, Steffen A, Johansson A, Brennan P, Johansson M

Publication type: Article

Publication status: Published

Journal: Scientific Reports

Year: 2016

Volume: 6

Online publication date: 04/11/2016

Acceptance date: 11/10/2016

Date deposited: 03/01/2017

ISSN (electronic): 2045-2322

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/srep36017

DOI: 10.1038/srep36017


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
3M Co, France
Associazione Italiana per la Ricerca sul Cancro-AIRC-Milan
Deutsches Krebsforschungszentrum
Dutch Ministry of Public Health, Welfare and Sports
Fondazione-Istituto Banco Napoli, Italy
French League against Cancer (LNCC), France
General Councils of France
German Federal Ministry of Education and Research
Gustave Roussy Institute (IGR), France
Hellenic Health Foundation
Italian Association for Research on Cancer (AIRC)
Italian National Research Council
Medical Research Council, United Kingdom
Mutuelle Generale de l'Education Nationale (MGEN), France
NordForsk (Centre of excellence programme HELGA), Norway
Regional Government of Vasterbotten, Sweden
Spanish Regional Government of Andalucia
Spanish Regional Government of Asturias
Spanish Regional Government of Murcia
Stavros Niarchos Foundation
Swedish Cancer Society
Swedish Scientific Council
World Cancer Research Fund (UK)
Cancer Research UK
Catalan Institute of Oncology, Spain
Compagnia di San Paolo
Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health
Deutsche Krebshilfe
Europe Against Cancer Program of the European Commission (SANCO)
Greek Ministry of Health
National Institute for Health and Medical Research (INSERM), France
Spanish Regional Government of Basque Country
Spanish Regional Government of Navarra
World Cancer Research Fund
RETICC DR06/0020ISCIII of the Spanish Ministry of Health

Share